XML 28 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Collaboration Agreements - Summary of Revenue Recognized Under the Collaboration Agreements - Additional Information 4 (Detail)
$ in Millions
3 Months Ended
Sep. 30, 2019
USD ($)
Japan [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing $ 0.2
Japan [Member] | Astellas Agreement [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations 12.3
Europe [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing 42.4
Europe [Member] | Astellas Agreement [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations 2.9
U.S./RoW and China [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing 186.6
U.S./RoW and China [Member] | AstraZeneca Agreements [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations $ 3.5